vs

Side-by-side financial comparison of Riley Exploration Permian, Inc. (REPX) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

Riley Exploration Permian, Inc. is the larger business by last-quarter revenue ($97.3M vs $76.2M, roughly 1.3× VIEMED HEALTHCARE, INC.). On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -5.3%). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -1.2%).

Riley Exploration Permian, Inc. is an independent energy company focused on exploration, development, and production of crude oil, natural gas, and natural gas liquids primarily in the US Permian Basin spanning Texas and New Mexico. It prioritizes cost-efficient onshore reserve development to supply reliable energy products to North American markets.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

REPX vs VMD — Head-to-Head

Bigger by revenue
REPX
REPX
1.3× larger
REPX
$97.3M
$76.2M
VMD
Growing faster (revenue YoY)
VMD
VMD
+30.8% gap
VMD
25.5%
-5.3%
REPX
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
-1.2%
REPX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
REPX
REPX
VMD
VMD
Revenue
$97.3M
$76.2M
Net Profit
$5.6M
Gross Margin
57.9%
Operating Margin
26.9%
11.0%
Net Margin
7.4%
Revenue YoY
-5.3%
25.5%
Net Profit YoY
30.7%
EPS (diluted)
$4.02
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
REPX
REPX
VMD
VMD
Q4 25
$97.3M
$76.2M
Q3 25
$106.9M
$71.9M
Q2 25
$85.4M
$63.1M
Q1 25
$102.5M
$59.1M
Q4 24
$102.7M
$60.7M
Q3 24
$102.3M
$58.0M
Q2 24
$105.4M
$55.0M
Q1 24
$99.7M
$50.6M
Net Profit
REPX
REPX
VMD
VMD
Q4 25
$5.6M
Q3 25
$16.3M
$3.5M
Q2 25
$30.5M
$3.2M
Q1 25
$28.6M
$2.6M
Q4 24
$4.3M
Q3 24
$25.7M
$3.9M
Q2 24
$33.5M
$1.5M
Q1 24
$18.8M
$1.6M
Gross Margin
REPX
REPX
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
REPX
REPX
VMD
VMD
Q4 25
26.9%
11.0%
Q3 25
27.0%
7.8%
Q2 25
33.7%
8.1%
Q1 25
48.3%
6.5%
Q4 24
31.2%
10.6%
Q3 24
17.1%
9.7%
Q2 24
50.9%
6.6%
Q1 24
50.7%
4.4%
Net Margin
REPX
REPX
VMD
VMD
Q4 25
7.4%
Q3 25
15.3%
4.9%
Q2 25
35.7%
5.0%
Q1 25
27.9%
4.4%
Q4 24
7.1%
Q3 24
25.1%
6.7%
Q2 24
31.8%
2.7%
Q1 24
18.8%
3.2%
EPS (diluted)
REPX
REPX
VMD
VMD
Q4 25
$4.02
$0.14
Q3 25
$0.77
$0.09
Q2 25
$1.44
$0.08
Q1 25
$1.36
$0.06
Q4 24
$0.52
$0.10
Q3 24
$1.21
$0.10
Q2 24
$1.59
$0.04
Q1 24
$0.94
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
REPX
REPX
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$13.5M
Total DebtLower is stronger
$247.9M
Stockholders' EquityBook value
$634.2M
$141.5M
Total Assets
$1.2B
$199.2M
Debt / EquityLower = less leverage
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
REPX
REPX
VMD
VMD
Q4 25
$13.5M
Q3 25
$11.1M
Q2 25
$20.0M
Q1 25
$10.2M
Q4 24
$17.5M
Q3 24
$11.3M
Q2 24
$8.8M
Q1 24
$7.3M
Total Debt
REPX
REPX
VMD
VMD
Q4 25
$247.9M
Q3 25
$367.0M
Q2 25
$275.2M
Q1 25
$249.3M
Q4 24
$269.5M
Q3 24
$288.6M
Q2 24
$322.7M
Q1 24
$341.8M
Stockholders' Equity
REPX
REPX
VMD
VMD
Q4 25
$634.2M
$141.5M
Q3 25
$566.5M
$133.6M
Q2 25
$556.9M
$139.7M
Q1 25
$532.4M
$134.8M
Q4 24
$510.6M
$131.4M
Q3 24
$507.4M
$125.0M
Q2 24
$489.0M
$119.4M
Q1 24
$434.6M
$116.3M
Total Assets
REPX
REPX
VMD
VMD
Q4 25
$1.2B
$199.2M
Q3 25
$1.2B
$202.4M
Q2 25
$1.0B
$184.6M
Q1 25
$994.9M
$178.1M
Q4 24
$993.5M
$177.1M
Q3 24
$997.9M
$169.5M
Q2 24
$1.0B
$163.9M
Q1 24
$956.4M
$154.9M
Debt / Equity
REPX
REPX
VMD
VMD
Q4 25
0.39×
Q3 25
0.65×
Q2 25
0.49×
Q1 25
0.47×
Q4 24
0.53×
Q3 24
0.57×
Q2 24
0.66×
Q1 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
REPX
REPX
VMD
VMD
Operating Cash FlowLast quarter
$64.9M
$18.4M
Free Cash FlowOCF − Capex
$9.7M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
REPX
REPX
VMD
VMD
Q4 25
$64.9M
$18.4M
Q3 25
$63.6M
$18.4M
Q2 25
$33.6M
$12.3M
Q1 25
$50.4M
$2.9M
Q4 24
$66.4M
$15.0M
Q3 24
$72.1M
$12.7M
Q2 24
$51.6M
$10.2M
Q1 24
$56.1M
$1.2M
Free Cash Flow
REPX
REPX
VMD
VMD
Q4 25
$9.7M
Q3 25
$10.7M
Q2 25
$4.1M
Q1 25
$-12.6M
Q4 24
$3.2M
Q3 24
$1.7M
Q2 24
$1.2M
Q1 24
$-4.8M
FCF Margin
REPX
REPX
VMD
VMD
Q4 25
12.7%
Q3 25
14.9%
Q2 25
6.5%
Q1 25
-21.4%
Q4 24
5.2%
Q3 24
3.0%
Q2 24
2.3%
Q1 24
-9.5%
Capex Intensity
REPX
REPX
VMD
VMD
Q4 25
11.5%
Q3 25
10.6%
Q2 25
12.9%
Q1 25
26.2%
Q4 24
19.5%
Q3 24
19.0%
Q2 24
16.3%
Q1 24
11.9%
Cash Conversion
REPX
REPX
VMD
VMD
Q4 25
3.27×
Q3 25
3.90×
5.23×
Q2 25
1.10×
3.88×
Q1 25
1.76×
1.09×
Q4 24
3.47×
Q3 24
2.81×
3.29×
Q2 24
1.54×
6.94×
Q1 24
2.99×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons